Comparative analysis of the evidence base for inclisiran, monoclonal antibodies (alirocumab, evolocumab), and bempedoic acid
| dc.contributor.author | Onopriienko, Danylo | |
| dc.date.accessioned | 2026-06-12T17:44:26Z | |
| dc.date.issued | 2026 | |
| dc.identifier.citation | Onopriienko D. Comparative analysis of the evidence base for inclisiran, monoclonal antibodies (alirocumab, evolocumab), and bempedoic acid / D. Onopriienko // ISIC─2026 : International scientific interdisciplinary conference of young scientific and medical students, Kharkiv, 25–27 May, 2026 / KhNMU. – Kharkiv, 2026. – P. 392─393. | |
| dc.identifier.uri | https://repo.knmu.edu.ua/handle/123456789/38165 | |
| dc.language.iso | en | |
| dc.publisher | KNMU | |
| dc.subject | 2026а | |
| dc.title | Comparative analysis of the evidence base for inclisiran, monoclonal antibodies (alirocumab, evolocumab), and bempedoic acid | |
| dc.type | Theses |